Superparamagnetic Nanoparticles and RNAi-Mediated Gene Silencing: Evolving Class of Cancer Diagnostics and Therapeutics

Figure 1

Surface modification of SPIONs. (a) Drug, (b) targeting ligand, (c) fluorophore, (d) therapeutic agent, and (e) linker.